Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 34Recruiting 18Active not recruiting 6Not yet recruiting 4Enrolling by invitation 3Unknown 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Neoplasms 2

Interventions

Cisplatin 504Cyclophosphamide 353Radiotherapy 349Carboplatin 347Capecitabine 328Oxaliplatin 319Paclitaxel 316Gemcitabine 315Docetaxel 308Fluorouracil 281apatinib 240Drug Therapy 239Bevacizumab 224camrelizumab 212Etoposide 199Irinotecan 176Doxorubicin 174Dexamethasone 159Leucovorin 158sintilimab 140Pemetrexed 136Cytarabine 136pembrolizumab 135anlotinib 135toripalimab 124S 1 (combination) 119Neoadjuvant Therapy 119Vincristine 118Rituximab 114Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Interventional × Patient Navigation × Clear all
NCT03226405 2020-04-21

Patient Navigation to Improve Patient-Centered Cancer Care

Massachusetts General Hospital

Phase NA Unknown
400 enrolled
Tumor-Agnostic

Neoplasms

NCT03305965 2017-10-10

The Effectiveness of Patient Navigation in Cancer Care

The Netherlands Cancer Institute

Phase NA Unknown
120 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡